Actavia Life Sciences, Inc. (RASP)
OTCMKTS · Delayed Price · Currency is USD
0.0040
-0.0285 (-87.69%)
At close: Jul 22, 2024
Actavia Life Sciences Market Cap
Actavia Life Sciences has a market cap or net worth of $3.09 million as of August 14, 2025. Its market cap has decreased by -96.98% in one year.
Market Cap
3.09M
Enterprise Value
3.39M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since October 14, 2016, Actavia Life Sciences's market cap has decreased from 71.15M to 3.09M, a decrease of -95.66%. That is a compound annual growth rate of -33.20%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 22, 2024 | 3.09M | 33.74% |
| Dec 14, 2021 | 2.31M | -33.00% |
| Dec 31, 2020 | 3.45M | -90.74% |
| Dec 13, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 20, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 1, 2016 | Upgrade Pro | Upgrade Pro |
| Oct 14, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Nika Pharmaceuticals | 972.72M |
| Veradigm | 789.71M |
| Tian'an Technology Group | 628.15M |
| Elite Pharmaceuticals | 608.19M |
| Glass House Brands | 543.74M |
| American Oncology Network | 393.37M |
| Northwest Biotherapeutics | 332.06M |
| CytoDyn | 300.87M |